Gene Company Pty Ltd vs. The Trustees of Columbia University in the City of New York et al.
Explore the PTAB proceeding IPR2024-00313 filed by Gene Company Pty Ltd on 2023-12-20. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2024-00313
Filing Date
2023-12-20
Accorded Filing Date
2023-12-20
Institution Decision Date
2024-06-24
Last Modified Date
2025-09-03
Proceeding Type
IPR
Termination Date
2025-06-23
Trial Status
Final Written Decision
Parties & Counsel
Petitioner
Gene Company Pty Ltd
Represented By
Mills, Jadet alPatent Owner / Respondent
Tribunal & Venue
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 3900 - Central Reexamination Unit (CRU)
Patent Information
Proceeding Documents
200Ex 3006 Exhibit
EX1079 -Public Redacted Version - Transcript of Leonide Saad Ph.D. Deposition Exhibit
Final Written Decision: JUDGMENT Final Written Decision Determining No Challenged Claims Unpatentable 35 U.S.C. § 318(a) Dismissing Petitioner’s Motion to Exclude Evidence as Moot 37 C.F.R. § 42.64 FINAL
Order ORDER
Other: Hearing transcript OTHER
Panel Change Order ORDER
Petitioner's Updated Exhibit List NOTICE
Patent Owner's Updated Exhibit List NOTICE
Petitioner's Demonstratives (Public) Exhibit
Patent Owner Demonstratives Exhibit
Ex. 3005 Exhibit
Petitioner's Reply in Support of Motion to Exclude REPLY
Patent Owner's Opposition to Petitioner's Motion to Exclude OPPOSITION
ScholarWorks Website Exhibit
Patent Owner's Updated Exhibit List NOTICE
Shauna Wiest Declaration Exhibit
Hussain 2018 Exhibit
PO Updated Exhibit List Served with Supp Evidence Exhibit
ORDER Setting Oral Argument 37 C.F.R. § 42.70 ORDER
Mowery 1979 Exhibit
Petitioner's Motion to Exclude MOTION
Patent Owner's Reply to Petitioner's Opposition to Patent Owner's Motion to Seal REPLY
Patent Owner's Request for Oral Argument MOTION
Petitioner's Request for Oral Argument MOTION
Patent Owner's Updated Power of Attorney NOTICE
Patent Owner's Updated Mandatory Notices NOTICE
Patent Owner's Sur-Reply OTHER
Petitioner's Opposition to Patent Owner's Motion to Seal OPPOSITION
Guengerich Depo Transcript (2025-01-24) Exhibit
Patent Owner's Updated Exhibit List NOTICE
E-mail granting authorization to file motion for withdrawal of Counsel Exhibit
Patent Owner's Notice of Deposition of Dr. F. Peter Guengerich NOTICE
Patent Owner's Motion to Seal and for Entry of Protective Order MOTION
Patent Owner's Objections to Evidence Submitted with Petitioner's Reply OTHER
Rebuttal Declaration of Dr. F. Peter Guengerich Exhibit
Alkeuspharma.com - Home Page Website Exhibit
Alkeus Pharma Web Page - Director's Profiles Exhibit
Monica Hennessey Linked In Profile Exhibit
Cyriac Joyce Linked In Profile Exhibit
Centrum Silver Adults Label (200 Tablets) Multivitamin Exhibit
Michael Song Linked In Profile Exhibit
Bain Capital - Current and former portfolio companies Exhibit
Shen, Liangbo L. et al. - American Academy of Ophthalmology – Natural History of Autosomal Recessive Stargardt Disease, (2019) Exhibit
RunyaoT. Linked In Profile Exhibit
Deposition Transcript of Del Priore, Lucian Exhibit
Christine Xu Linked In Profile Exhibit
Rowan Walrath, “Vertex founder Josh Boger is back in biotech. Here’s why he ‘unretired.” Boston Business Journal (Jun. 11, 2023) Exhibit
Gildeuretinol Slows Progression of Stargardt Disease (10-24) Exhibit
Heier, Jeffrey S. et al. - Pegcetacoplan for the Treatment of Geographic Atrophy, (2023) Exhibit
Ben Fidler, “An unconventional drug startup lures Vertex founder Josh Boger back to biotech,” BioPharmaDive (Jun. 5, 2023) Exhibit
Deposition Transcript of Prestwich, Ph.D., Glenn D Exhibit
REDACTED PUBLIC VERSION Petitioner's Reply REPLYTOOPP
Timmer Report Alkeus, a Bootstrap Success Story Exhibit
Jonathan Saltzman, “Cambridge biotech raises $150 million and rehires founder of Vertex,” Boston Globe (Jun. 5, 2023) Exhibit
Ilyas Washington, PubMed Publication Entries, 2001-2007 Exhibit
Public Redacted Version - Transcript of Leonide Saad Ph.D. Deposition Exhibit
Luke Timmerman, “Alkeus, A Bootstrap Success Story, Grows Up With $150M Series B”, Timmerman Report (Jun. 2023) Exhibit
Glenn J. Jaffee, et al., “C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration, Ophthalmology” Exhibit
Ex. 3003 Exhibit
Boyer 2024 Exhibit
Patent Owner's Updated Exhibit List NOTICE
Notice of Deposition of Leonide Saad NOTICE
Notice of Deposition of Glenn Prestwhich NOTICE
Petitioner's Notice of Deposition of Dr. Del Priore NOTICE
Petitioner's Opposition to Patent Owner's Motion to Seal OPPOSITION
Ex. 3002 Exhibit
Petitioner's Objections to Evidence NOTICE
Mihai 2013 Exhibit
Massof 1993 Exhibit
NCT02402660 Exhibit
Greenhill Declaration Part 1 Exhibit
Gollapalli 2004 Exhibit
Greene 1968 Exhibit
Kennedy 1995 Exhibit
Owsley 2000 Exhibit
Anslyn 2006 Exhibit
Villablanca 1995 Exhibit
Orphanet 2003 Exhibit
Sherman 2013 Exhibit
2017.10.06 FDA News Release Exhibit
Del Priore 2024 Exhibit
Miedziak 2000 Exhibit
Bok 1993 Exhibit
NCT00429936 Exhibit
Wiest Declaration Part 2 Exhibit
2024.09.17 Alkeus Press Release Exhibit
Anderson 1995 Exhibit
Mamor and Gamel 1993 Exhibit
Hong 1994 Exhibit
NEI Stargardt Disease 2024 Exhibit
Guymer 2006 Exhibit
Freemantle 2003 Exhibit
Greenhill Declaration Part 2 Exhibit
Verdegem 1997 Exhibit
NCT00485394 Exhibit
AREDS2 Exhibit
Sternberg 2010 Exhibit
Michaelides 2003 Exhibit
Isotretinoin (Wayback 2008.06.03) Exhibit
Petrukhin 2013 Exhibit
Han 2024 Exhibit
Scholl 2024 Exhibit
Kay 2022 Exhibit
Gorin 2024 Exhibit
Kim 2004 Exhibit
FDA Stargardt Disease 2022 Exhibit
Baehr 2003 Exhibit
Stokkermans 2009 Exhibit
Dragnev 2000 Exhibit
Voo 2004 Exhibit
Saad Declaration Exhibit
Caruso 2008 Exhibit
Scholl 2019 Exhibit
Sears 2017 Exhibit
Li 2005 Exhibit
Issa 2015 Exhibit
Camerini 2001 Exhibit
Johnson 2002 Exhibit
Greenhill Declaration Part 3 Exhibit
Wiest Declaration Part 1 Exhibit
Seddon 1994 Exhibit
Harper’s Biochemistry Exhibit
FDA Patient Listening Sessions 2024 Exhibit
Travis 2007 Exhibit
Koenekoop 2003 Exhibit
Mowery 1979 Exhibit
Robison 1980 Exhibit
Shapiro 2015 Exhibit
Soriatan (Wayback 2008.06.16) Exhibit
Hamel 2006 Exhibit
Cocce 2018 Exhibit
NCT04239625 Exhibit
van Leeuwen 2005 Exhibit
Andrew F. Calman MD PhD Contact this Expert Witness Exhibit
Strauss 2019 Exhibit
NCT00346853 Exhibit
Charters 2024 Exhibit
Guengerich Email to IW (09.21.2010) Exhibit
Karan 2005 Exhibit
Patent Owner's Motion to Seal and Enter Default Protective Order MOTION
Oxford Dictionary 2006 Exhibit
NCT02230228 Exhibit
Goldstein 2005 Exhibit
Scholl 2016 Exhibit
Patent Owner Response RESPONSE
Westheimer 1961 Exhibit
NCT00060749 Exhibit
Tsui 2007 Exhibit
Jurgensmeier 2007 Exhibit
Cartmel 1999 Exhibit
Katz 1986 Exhibit
Mata 2013 Exhibit
Krauser 2005 Exhibit
NCT00307398 Exhibit
Guengerich 2016 Exhibit
Lamb 2004 Exhibit
Prestwich CV Exhibit
Guengerich Depo Transcript Exhibit
Nelson 2003 Exhibit
Rattner 2006 Exhibit
Rando 2001 Exhibit
Weng 1999 Exhibit
Katz 1987 Exhibit
Sakai 1996 Exhibit
Calman Depo Transcript Exhibit
Owsley 2001 Exhibit
UCSF Stargardt Disease 2024 Exhibit
Puduvalli 2004 Exhibit
Del Priore CV Exhibit
Glenn 1994 Exhibit
2024.01.10 Alkeus Press Release Exhibit
Nason-Burchenal 1999 Exhibit
Ma 2011 Exhibit
Prestwich Declaration Exhibit
Rózanowska 2005 Exhibit
Belite Bio - Company Presentation Exhibit
FFB 2023 Exhibit
Patent Owner's Updated Exhibit List NOTICE
Pirali 2019 Exhibit
Maiti 2006 Exhibit
Piotter 2021 Exhibit
Fisher 2006 Exhibit
FDA Breakthrough Therapy Exhibit
2021.07.14 Alkeus Press Release Exhibit
Penniston 2006 Exhibit
Guengerich Email to IW (09.24.2010) Exhibit
Alkeus Website Exhibit
Brody 2001 Exhibit
NCT03845582 Exhibit
Ben-Shabat 2001 Exhibit
Wiest Declaration Part 3 Exhibit
Ben-Shabat 2002 Exhibit
Katz 1992 Exhibit
Tan 2008 Exhibit
Scholl 2022 Exhibit
Howes 2006 Exhibit
Maeda 2006 Exhibit
Aleman 2007 Exhibit
Mukherjee 2014 Exhibit
Parodi 2015 Exhibit
Download Proceeding Documents
Case IPR2024-00313 • 200 documents
Preparing ZIP Archive
Email verified! Bundling proceeding documents from USPTO. Your download will start automatically in a few seconds...